newsNew Drug Application submitted for first-ever Progeria treatment20 December 2019 | By European Pharmaceutical ReviewA New Drug Application has been submitted to the FDA for lonafarnib, the first-ever treatment for Progeria and Progeroid Laminopathies.
newsTrial results show compound makes radiotherapy more effective16 November 2018 | By European Pharmaceutical ReviewA trial has shown that radiotherapy is more effective when levels of ropidoxuridine in a patients' body reach a certain level...
news5-FU cream found to reduce the risk of squamous cell carcinoma3 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Clinical trial results provide evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of SCC...
